A 14-year-old girl with perinatally acquired human immunodeficiency virus infection had fatal intravascular hemolysis after intravenous administration of ceftriaxone. Laboratory studies confirmed the presence of an antibody against ceftriaxone in the serum and on the patient's red blood cells. No evidence of sepsis, glucose-6-phosphate dehydrogenase deficiency or anaphylaxis was found.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0022-3476(98)70236-7 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!